trending Market Intelligence /marketintelligence/en/news-insights/trending/tC2an3-4ALzLdBplH-wRew2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Nabriva completes rights offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Nabriva completes rights offering

Nabriva Therapeutics AG raised $21 million in a rights offering.

It offered 588,127 common shares, including 3,267,750 American depositary shares, where each ADS represents a 10th of a common share.

The Austria-based biopharmaceutical company plans to use these funds for general corporate purposes, including working capital and pre-commercial activities.

Cantor Fitzgerald & Co. is financial adviser to Nabriva and is the sole book-running manager of the underwritten offering.

The expected delivery date is Dec. 19.